Articles

First Septic Shock Treatment proved saviour for Child at Levine Children’s Hospital

Read more

Lantern Pharma joins Genomic England’s Discovery Forum industry partnership

Read more

Shawn M. Cross appointed CEO of GT Biopharma

Read more

FDA sanctions breakthrough treatment for specific kind of Prostate Cancer

Read more

PharmaMar signs licensing agreement with Seattle Genetics

Read more

Dr. Christine Esau appointed VP of Research and Development for Arcturus Therapeutics

Read more

Charles River Laboratories obtain MPI Research

Read more

Lynn Lewis appointed Senior VP Global Sales of Envigo

Read more

FDA paves way for marketing of Viz.AI Contact application

Read more

Michael Nolte appointed CEO of Bracket

Read more